Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden page with minimal header/footer, replacing the study details, sections, and links; users cannot view the clinical study information linked to NCT03519997.
    Difference
    20%
    Check dated 2026-09-20T02:02:34.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page footer displays a new Revision: v3.6.6, replacing the previous v3.6.5, indicating a small update to the page.
    Difference
    0.1%
    Check dated 2026-08-29T23:42:57.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update. The core study details and user-facing content appear unchanged.
    Difference
    0.1%
    Check dated 2026-08-08T20:47:01.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating the current page build. This is a minor version update that tracks the latest iteration of the page rather than altering its content.
    Difference
    0.1%
    Check dated 2026-07-25T13:00:32.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Study status updated to Completed and the Study Completion (Actual) date shown as 2026-03-09. The previous Active, not recruiting label and its related values were removed.
    Difference
    0.4%
    Check dated 2026-07-11T05:12:09.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The study documents reference has been updated to revision v3.6.3, replacing the previous v3.6.2. This indicates the trial materials have been refreshed to the latest revision.
    Difference
    0.1%
    Check dated 2026-07-03T23:50:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.